• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国阿片类药物处方的地域差异

Geographic variation in opioid prescribing in the U.S.

机构信息

U.S. Health Division, Abt Associates Inc., Cambridge, Massachusetts 02138, USA.

出版信息

J Pain. 2012 Oct;13(10):988-96. doi: 10.1016/j.jpain.2012.07.007.

DOI:10.1016/j.jpain.2012.07.007
PMID:23031398
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3509148/
Abstract

UNLABELLED

Estimates of geographic variation among states and counties in the prevalence of opioid prescribing are developed using data from a large (135 million) representative national sample of opioid prescriptions dispensed during 2008 by 37,000 retail pharmacies. Statistical analyses are used to estimate the extent to which county variation is explained by characteristics of resident populations, their healthcare utilization, proxy measures of morbidity, availability of healthcare resources, and prescription monitoring laws. Geographic variation in prevalence of prescribed opioids is large, greater than the variation observed for other healthcare services. Counties having the highest prescribing rates for opioids were disproportionately located in Appalachia and in southern and western states. The number of available physicians was by far the strongest predictor of amounts prescribed, but only one-third of county variation is explained by the combination of all measured factors. Wide variation in prescribing opioids reflects weak consensus regarding the appropriate use of opioids for treating pain, especially chronic noncancer pain. Patients' demands for treatment have increased, more potent opioids have become available, an epidemic of abuse has emerged, and calls for increased government regulation are growing. Greater guidance, education, and training in opioid prescribing are needed for clinicians to support appropriate prescribing practices.

PERSPECTIVE

Wide geographic variation that does not reflect differences in the prevalence of injuries, surgeries, or conditions requiring analgesics raises questions about opioid prescribing practices. Low prescription rates may indicate undertreatment, while high rates may indicate overprescribing and insufficient attention to risks of misuse.

摘要

未加标签

本研究利用 2008 年全美 37000 家零售药店处方的 1.35 亿个阿片类药物样本,估计了各州和各县之间阿片类药物处方流行率的地域差异。通过统计分析,估计了居民人口特征、医疗保健利用情况、发病率替代指标、医疗资源的可及性和处方监测法规对县内差异的解释程度。处方类阿片流行率的地域差异很大,超过了其他医疗服务观察到的差异。处方类阿片最高的县不成比例地分布在阿巴拉契亚地区以及南部和西部各州。可用医师数量是处方数量的最强预测因素,但所有测量因素的综合解释仅能解释三分之一的县内差异。阿片类药物处方的广泛差异反映出在使用阿片类药物治疗疼痛,尤其是慢性非癌性疼痛方面,缺乏共识。患者对治疗的需求增加,更有效的阿片类药物已经上市,滥用现象已经出现,政府监管的呼声也越来越高。需要对临床医生进行更多的阿片类药物处方指导、教育和培训,以支持适当的处方实践。

观点

这种与受伤、手术或需要镇痛的疾病的流行率无差异的广泛地域差异,引发了对阿片类药物处方实践的质疑。处方率低可能表明治疗不足,而处方率高可能表明过度治疗以及对滥用风险的关注不足。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37d4/3509148/b642a2fe0c6c/nihms399782f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37d4/3509148/b642a2fe0c6c/nihms399782f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/37d4/3509148/b642a2fe0c6c/nihms399782f1.jpg

相似文献

1
Geographic variation in opioid prescribing in the U.S.美国阿片类药物处方的地域差异
J Pain. 2012 Oct;13(10):988-96. doi: 10.1016/j.jpain.2012.07.007.
2
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
3
Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.受控物质处方模式 - 处方行为监测系统,八个州,2013 年。
MMWR Surveill Summ. 2015 Oct 16;64(9):1-14. doi: 10.15585/mmwr.ss6409a1.
4
Vital Signs: Changes in Opioid Prescribing in the United States, 2006-2015.生命体征:2006 - 2015年美国阿片类药物处方的变化
MMWR Morb Mortal Wkly Rep. 2017 Jul 7;66(26):697-704. doi: 10.15585/mmwr.mm6626a4.
5
Trends and Patterns of Geographic Variation in Opioid Prescribing Practices by State, United States, 2006-2017.2006-2017 年美国各州阿片类药物处方实践的地域差异趋势和模式。
JAMA Netw Open. 2019 Mar 1;2(3):e190665. doi: 10.1001/jamanetworkopen.2019.0665.
6
Increased opioid use following rotator cuff repair associated with prior opioid use and surgeon prescription patterns.肩袖修复术后阿片类药物使用增加与术前阿片类药物使用和外科医生处方模式有关。
J Shoulder Elbow Surg. 2020 Jul;29(7S):S115-S125. doi: 10.1016/j.jse.2020.04.037. Epub 2020 Jun 9.
7
Florida Controlled Substance Prescribing佛罗里达州受管制物质处方开具
8
State pain management clinic policies and county opioid prescribing: A fixed effects analysis.州疼痛管理诊所政策与县阿片类药物处方:固定效应分析。
Drug Alcohol Depend. 2020 Nov 1;216:108239. doi: 10.1016/j.drugalcdep.2020.108239. Epub 2020 Aug 18.
9
Opioid Prescribing Behaviors - Prescription Behavior Surveillance System, 11 States, 2010-2016.阿片类药物处方行为-处方行为监测系统,11 个州,2010-2016 年。
MMWR Surveill Summ. 2020 Jan 31;69(1):1-14. doi: 10.15585/mmwr.ss6901a1.
10
Responsible Controlled Substance and Opioid Prescribing负责任的管制药品和阿片类药物处方开具

引用本文的文献

1
Opioid use in postoperative pain management of pediatric appendectomy patients in Japan.日本小儿阑尾切除术后疼痛管理中阿片类药物的使用情况。
J Anesth. 2025 Jun 14. doi: 10.1007/s00540-025-03525-7.
2
Implementation of Medication Disposal Programs and Availability of Same-Day Naloxone at Community Pharmacies: Protocol for a Secret Shopper Caller Approach.社区药房药物处置计划的实施及同日纳洛酮的可及性:秘密购物者致电法方案
JMIR Res Protoc. 2025 Jun 10;14:e64344. doi: 10.2196/64344.
3
Opioid-Prescribing Trends in Dermatology From 2014 to 2020 in the United States.

本文引用的文献

1
Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research.缓解美国的疼痛:转变预防、护理、教育和研究的蓝图。
Mil Med. 2016 May;181(5):397-9. doi: 10.7205/MILMED-D-16-00012.
2
Time to take stock: a meta-analysis and systematic review of analgesic treatment disparities for pain in the United States.评估时机:美国镇痛治疗中疼痛差异的荟萃分析和系统评价。
Pain Med. 2012 Feb;13(2):150-74. doi: 10.1111/j.1526-4637.2011.01310.x. Epub 2012 Jan 13.
3
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
2014年至2020年美国皮肤科阿片类药物处方趋势
Cureus. 2024 Nov 25;16(11):e74425. doi: 10.7759/cureus.74425. eCollection 2024 Nov.
4
Barriers to and facilitators of buprenorphine dispensing for opioid use disorder: Evidence from focus groups in Appalachian Kentucky.用于阿片类物质使用障碍的丁丙诺啡配药的障碍与促进因素:来自肯塔基州阿巴拉契亚地区焦点小组的证据
J Am Pharm Assoc (2003). 2025 Mar-Apr;65(2):102308. doi: 10.1016/j.japh.2024.102308. Epub 2024 Dec 4.
5
Postoperative Opioid Administration and Prescription Practices Following Hysterectomy in Two Tertiary Care Centres: A Comparative Cohort Study between Canada and Austria.两家三级医疗中心子宫切除术后阿片类药物的使用与处方实践:加拿大与奥地利的一项比较队列研究
J Clin Med. 2024 Oct 10;13(20):6031. doi: 10.3390/jcm13206031.
6
Risk of prolonged postoperative opioid use after elective shoulder replacement: a nationwide cohort study of 5,660 patients from the Danish Shoulder Arthroplasty Registry.择期肩关节置换术后长期使用阿片类药物的风险:来自丹麦肩关节置换登记处的 5660 例患者的全国性队列研究。
Acta Orthop. 2024 Aug 15;95:433-439. doi: 10.2340/17453674.2024.41090.
7
The association between primary care appointment lengths and opioid prescribing for common pain conditions.基层医疗预约时长与常见疼痛病症阿片类药物处方之间的关联。
BMC Health Serv Res. 2024 Jul 2;24(1):776. doi: 10.1186/s12913-024-11215-5.
8
Association of Opioid Use Disorder Diagnosis with Management of Acute Low Back Pain: A Medicare Retrospective Cohort Analysis.阿片类药物使用障碍诊断与急性腰痛管理的关联:一项医疗保险回顾性队列分析。
J Gen Intern Med. 2024 Aug;39(11):2097-2105. doi: 10.1007/s11606-024-08799-3. Epub 2024 Jun 3.
9
Managing an epidemic within a pandemic: orthopedic opioid prescribing trends during COVID-19.大流行期间管理流行病:COVID-19 期间骨科阿片类药物处方趋势。
Arch Orthop Trauma Surg. 2024 Jun;144(6):2473-2479. doi: 10.1007/s00402-024-05329-y. Epub 2024 Apr 25.
10
Toxicology Test Results for Public Health Surveillance of the Opioid Epidemic: Retrospective Analysis.阿片类药物流行的公共卫生监测毒理学测试结果:回顾性分析
Online J Public Health Inform. 2023 Sep 28;15:e50936. doi: 10.2196/50936. eCollection 2023.
生命体征:1999 年至 2008 年美国处方类阿片类止痛药过量。
MMWR Morb Mortal Wkly Rep. 2011 Nov 4;60(43):1487-92.
4
Forward: CDC Health Disparities and Inequalities Report - United States, 2011.前言:《2011年美国疾病控制与预防中心健康差异与不平等报告》
MMWR Suppl. 2011 Jan 14;60(1):1-2.
5
Time to tackle unwarranted variations in practice.是时候解决医疗实践中不必要的差异了。
BMJ. 2011 Mar 17;342:d1513. doi: 10.1136/bmj.d1513.
6
Geographic variation in the quality of prescribing.处方质量的地域差异。
N Engl J Med. 2010 Nov 18;363(21):1985-8. doi: 10.1056/NEJMp1010220. Epub 2010 Nov 3.
7
Geographic variation in Medicare drug spending.医疗保险药品支出的地区差异。
N Engl J Med. 2010 Jul 29;363(5):405-9. doi: 10.1056/NEJMp1004872. Epub 2010 Jun 9.
8
Opioid controls: regulate to educate.阿片类药物管控:规范以开展教育。
Pain Med. 2010 Apr;11(4):480-1. doi: 10.1111/j.1526-4637.2010.00822.x. Epub 2010 Mar 22.
9
Opioid analgesics for pain control: wisconsin physicians' knowledge, beliefs, attitudes, and prescribing practices.用于疼痛控制的阿片类镇痛药:威斯康星州医生的知识、信念、态度和处方实践。
Pain Med. 2010 Mar;11(3):425-34. doi: 10.1111/j.1526-4637.2009.00761.x. Epub 2009 Dec 9.
10
Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007.整合九种处方阿片类镇痛药和/或四种信号检测系统,以总结2007年美国全州范围内的处方药滥用情况。
Pharmacoepidemiol Drug Saf. 2009 Sep;18(9):778-90. doi: 10.1002/pds.1780.